SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-002727
Filing Date
2021-01-11
Accepted
2021-01-11 08:08:26
Documents
14
Period of Report
2021-01-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm212231d1_8k.htm   iXBRL 8-K 27001
2 EXHIBIT 99.1 tm212231d1_ex99-1.htm EX-99.1 38057
6 GRAPHIC tm212231d1_ex99-1img001.jpg GRAPHIC 4816
  Complete submission text file 0001104659-21-002727.txt   255187

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA knsa-20210111.xsd EX-101.SCH 3184
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE knsa-20210111_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE knsa-20210111_pre.xml EX-101.PRE 22709
7 EXTRACTED XBRL INSTANCE DOCUMENT tm212231d1_8k_htm.xml XML 3611
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38492 | Film No.: 21519340
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences